Is Holmium Laser Enucleation of Prostate a Good Surgical Alternative in Benign Prostatic Hyperplasia Management? A Review Article
Journal of Lasers in Medical Sciences,
Vol. 11 No. 2 (2020),
15 March 2020
,
Page 197-203
Abstract
Several therapeutic approaches such as holmium laser enucleation of the prostate (HoLEP) have been introduced to relieve bladder outlet obstruction caused by benign prostatic hyperplasia (BPH). Compared with other techniques including the transurethral resection of the prostate (TURP) and simple open prostatectomy, HoLEP results in a shorter hospital stay and catheterization time and fewer blood loss and transfusions. HoLEP is a size-independent treatment option for BPH with average gland size from 36 g to 170 g. HoLEP is a safe procedure in patients receiving an anticoagulant and has no significant influence on the hemoglobin level. Also, HoLEP is an easy and safe technique in patients with a prior history of prostate surgery and a need for retreatment because of adenoma regrowth. The postoperative erectile dysfunction rate of patients treated with HoLEP is similar to TURP or open prostatectomy and about 77% of these patients experience loss of ejaculation. Patients with transitional zone volume less than 30 mL may suffer from persistent stress urinary incontinence following HoLEP so other surgical techniques like bipolar TURP are a good choice for these patients. In young patients, considering HoLEP with high prostate-specific antigen density and a negative standard template prostate biopsy, multiparametric MRI needs to be considered to exclude prostate cancer.
- Laser
- Minimal invasive
- HoLEP
- Prostate surgery
- Prostate hyperplasia
- Transurethral resection of prostate
How to Cite
References
REFERENCE:
Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, et al. The prevalence of
prostatism: a population-based survey of urinary symptoms. J Urol. 1993;150(1):85-9. doi:
1016/s0022-5347(17)35405-8.
Guess HA, Arrighi HM, Metter EJ, Fozard JL. Cumulative prevalence of prostatism matches the
autopsy prevalence of benign prostatic hyperplasia. Prostate. 1990;17(3):241-6. doi:
1002/pros.2990170308.
Karami H, Hassanzadeh-Hadad A, Fallah-Karkan M. Comparing monotherapy with tadalafil or
tamsulosin and their combination therapy in men with benign prostatic hyperplasia: a randomized
clinical trial. Urol J. 2016;13(6):2920-6. doi: 10.22037/uj.v13i6.3666.
Shigemura K, Fujisawa M. Current status of holmium laser enucleation of the prostate. Int J Urol.
;25(3):206-11. doi: 10.1111/iju.13507.
Marien T, Kadihasanoglu M, Miller NL. Holmium laser enucleation of the prostate: patient
selection and perspectives. Res Rep Urol. 2016;8:181-92. doi: 10.2147/RRU.S100245.
Razzaghi MR, Fallah Karkan M, Ghiasy S, Javanmard B. Laser application in iran urology: a
narrative review. J Lasers Med Sci. 2018;9(1):1-6. doi: 10.15171/jlms.2018.01.
Razzaghi MR, Mazloomfard MM, Mokhtarpour H, Moeini A. Diode laser (980 nm) vaporization in
comparison with transurethral resection of the prostate for benign prostatic hyperplasia: randomized
clinical trial with 2-year follow-up. Urology. 2014;84(3):526-32. doi: 10.1016/j.urology.2014.05.027.
Sadeghi K, Hamishehkar H, Najmeddin F, Ahmadi A, Hazrati E, Honarmand H, et al. High-dose
amikacin for achieving serum target levels in critically ill elderly patients. Infect Drug Resist.
;11:223-8. doi: 10.2147/IDR.S150839.
Kahokehr AA, Gilling PJ. Which laser works best for benign prostatic hyperplasia? Curr Urol Rep.
;14(6):614-9. doi: 10.1007/s11934-013-0351-8.
Javanmard B, Fallah Karkan M, Razzaghi MR, Ghiasy S, Ranjbar A, Rahavian A. Surgical
management of vesical stones in children: a comparison between open cystolithotomy, percutaneous
cystolithotomy and transurethral cystolithotripsy with holmium-YAG Laser. J Lasers Med Sci.
;9(3):183-7. doi: 10.15171/jlms.2018.33.
Abedi AR, Razzaghi MR, Allameh F, Aliakbari F, Fallahkarkan M, Ranjbar A. Pneumatic Lithotripsy
Versus Laser Lithotripsy for Ureteral Stones. J Lasers Med Sci. 2018;9(4):233-6. doi:
15171/jlms.2018.42.
Ghiasy S, Fallah-Karkan M, Razzaghi MR, Ranjbar A, Rahavian A, Javanmard B. Is Holmium laser
an appropriate modality to treat genital warts? J Lasers Med Sci. 2019;10(1):70-74. doi:
15171/jlms.2019.11.
Fallah karkan M, Razzaghi MR, Karami H, Ghiasy S, Tayyebiazar A, Javanmard B. Experience of
transurethral urethrotomy with Holmium:YAG laser. J Lasers Med Sci. 2019;10(2):104-7. doi:
15171/jlms.2019.17.
Fallah Karkan M, Razzaghi MR, Javanmard B, Tayyebiazar A, Ghiasy S, Montazeri S. Holmium:
YAG Laser Incision of Bladder Neck Contracture Following Radical Retropubic Prostatectomy. Nephro-
Urol Mon. 2019;11(1):e88677. doi: 10.5812/numonthly.88677.
Mottet N, Anidjar M, Bourdon O, Louis JF, Teillac P, Costa P, et al. Randomized comparison of
transurethral electroresection and holmium: YAG laser vaporization for symptomatic benign prostatic
hyperplasia. J Endourol. 1999;13(2):127-30. doi: 10.1089/end.1999.13.127.
Fallah Karkan M, Ghiasy S, Ranjbar A, Javanmard B. Evaluation of 200 Mm, 365 Mm and 500 Mm
fibers of Ho: YAG laser in transurethral lithotripsy of ureteral: a randomize control trial. J Lasers Med Sci.
;9(1):69-72. doi: 10.15171/jlms.2018.14.
Abedi AR, Allameh F, Razzaghi MR, Fadavi B, Qashqai H, Najafi S, et al. The efficacy and safety of
laser lithotripsy in pregnancy. J Lasers Med Sci. 2017;8(2):84-7. doi: 10.15171/jlms.2017.15.
Elshal AM, El-Nahas AR, Ghazy M, Nabeeh H, Laymon M, Soltan M, et al. Low-Power Vs High-
Power Holmium Laser Enucleation of the Prostate: Critical Assessment through Randomized Trial.
Urology. 2018;121:58-65. doi: 10.1016/j.urology.2018.07.010.
Xu C, Xu Z, Lin C, Feng S, Sun M, Chen J, et al. Holmium laser enucleation of the prostate:
Modified two-Lobe technique versus traditional three-Lobe technique—A randomized study. Biomed
Res Int. 2019;2019:3875418. doi: 10.1155/2019/3875418.
Kuo RL, Paterson RF, Kim SC, Siqueira TM Jr, Elhilali MM, Lingeman JE. Holmium Laser
Enucleation of the Prostate (HoLEP): A Technical Update. World J Surg Oncol. 2003;1(1):6. doi:
1186/1477-7819-1-6.
Humphreys MR, Miller NL, Handa SE, Terry C, Munch LC, Lingeman JE. Holmium laser
enucleation of the prostate—outcomes independent of prostate size? J Urol. 2008;180(6):2431-5. doi:
1016/j.juro.2008.08.019.
Shah HN, Sodha HS, Kharodawala SJ, Khandkar AA, Hegde SS, Bansal MB. Influence of prostate
size on the outcome of holmium laser enucleation of the prostate. BJU Int. 2008;101(12):1536-41. doi:
1111/j.1464-410X.2007.07434.x.
Seki N, Tatsugami K, Naito S. Holmium laser enucleation of the prostate: comparison of
outcomes according to prostate size in 97 Japanese patients. J Endourol. 2007;21(2):192-6. doi:
1089/end.2006.0123.
Kim KS, Choi JB, Bae WJ, Kim SJ, Cho HJ, Hong SH, et al. Comparison of Photoselective
Vaporization versus holmium laser enucleation for treatment of benign prostate hyperplasia in a small
prostate volume. PLoS One. 2016;11(5):e0156133. doi: 10.1371/journal.pone.0156133.
Krambeck AE, Handa SE, Lingeman JE. Holmium laser enucleation of the prostate for prostates
larger than 175 grams. J Endourol. 2010;24(3):433-7. doi: 10.1089/end.2009.0147.
Matlaga BR, Kim SC, Kuo RL, Watkins SL, Lingeman JE. Holmium laser enucleation of the prostate
for prostates of > 125 mL. BJU Int. 2006;97(1):81-4. doi: 10.1111/j.1464-410X.2006.05898.x.
Kuntz RM, Lehrich K, Ahyai SA. Holmium laser enucleation of the prostate versus open
prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical
trial. Eur Urol. 2008;53(1):160-8. doi: 10.1016/j.eururo.2007.08.036.
Naspro R, Suardi N, Salonia A, Scattoni V, Guazzoni G, Colombo R, et al. Holmium laser
enucleation of the prostate versus open prostatectomy for prostates > 70 g: 24-month follow-up. Eur
Urol. 2006;50(3):563-8. doi: 10.1016/j.eururo.2006.04.003.
Wisenbaugh ES, Nunez-Nateras R, Mmeje CO, Warner JN, Humphreys MR. Does prostate
morphology affect outcomes after holmium laser enucleation? Urology. 2013;81(4):844-8. doi:
1016/j.urology.2013.01.006.
Gerridzen RG, Futter NG. Ten-year review of vesical diverticula. Urology. 1982;20(1):33-5. doi:
1016/0090-4295(82)90532-5.
Agarwal DK, Krambeck AE. Holmium laser enucleation of the prostate is an effective treatment
in patients with concomitant bladder diverticula and outlet obstruction. World J Urol. 2018;36(1):87-90.
doi: 10.1007/s00345-017-2114-5.
Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, et al. Perioperative
management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis:
American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2
Suppl):e326S-e350S. doi: 10.1378/chest.11-2298.
Romero-Otero J, García-González L, García-Gómez B, Justo-Quintas J, García-Rojo E, González-
Padilla DA, et al. Factors influencing intraoperative blood loss in patients undergoing Holmium Laser
Enucleation of the Prostate (HoLEP) for Benign Prostatic Hyperplasia: a large multicenter analysis.
Urology. 2019. doi: 10.1016/j.urology.2019.06.024.
De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, et al. General
mechanisms of coagulation and targets of anticoagulants (section I). Position paper of the ESCworking
group on thrombosis--task force on anticoagulants in heart disease. Thromb Haemost. 2013;109(4):569-
doi: 10.1160/TH12-10-0772.
Dall M, Primdahl A, Damborg F, Nymark T, Hallas J. The association between use of serotonergic
antidepressants and perioperative bleeding during total hip arthroplasty–a cohort study. Basic Clin
Pharmacol Toxicol. 2014;115(3):277-81. doi: 10.1111/bcpt.12218.
Gilling PJ, Wilson LC, King CJ, Westenberg AM, Frampton CM, Fraundorfer MR. Long‐term results
of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection
of the prostate: results at 7 years. BJU Int. 2012;109(3):408-11. doi: 10.1111/j.1464-410X.2011.10359.x.
Gilling PJ, Aho TF, Frampton CM, King CJ, Fraundorfer MR. Holmium laser enucleation of the
prostate: results at 6 years. Eur Urol. 2008;53(4):744-9. doi: 10.1016/j.eururo.2007.04.052.
Elshal AM, Elmansy HM, Elhilali MM. Feasibility of holmium laser enucleation of the prostate
(HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH). BJU Int. 2012;110(11 Pt C):E845-E50.
doi: 10.1111/j.1464-410X.2012.11290.x.
Marien T, Kadihasanoglu M, Tangpaitoon T, York N, Blackburne A, Abdul-Muhsin H, et al. MP42-
Outcomes of HoLEP performed in the retreatment setting. J Urol. 2016;195(4S):e571-e572.
doi.org/10.1016/j.juro.2016.12.098
Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, et al. Lower urinary tract symptoms
and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol.
;44(6):637-49. doi: 10.1016/j.eururo.2003.08.015.
Soderdahl DW, Knight RW, Hansberry KL. Erectile dysfunction following transurethral resection
of the prostate. J Urol. 1996;156(4):1354-6. doi: 10.1016/S0022-5347(01)65585-X.
Tscholl R, Largo M, Poppinghaus E, Recker F, Subotic B. Incidence of erectile impotence
secondary to transurethral resection of benign prostatic hyperplasia, assessed by preoperative and
postoperative Snap Gauge tests. J Urol. 1995;153(5):1491-3. doi: 10.1016/S0022-5347(01)67442-1.
Hanbury DC, Sethia KK. Erectile function following transurethral prostatectomy. Br J Urol.
;75(1):12-3. doi: 10.1111/j.1464-410x.1995.tb07224.x.
Montorsi F, Naspro R, Salonia A, Suardi N, Briganti A, Zanoni M, et al. Holmium laser enucleation
versus transurethral resection of the prostate: results from a 2-center prospective randomized trial in
patients with obstructive benign prostatic hyperplasia. J Urol. 2008;179(5 Suppl):S87-S90. doi:
1016/j.juro.2008.03.143.
Naspro R, Bachmann A, Gilling P, Kuntz R, Madersbacher S, Montorsi F, et al. A review of the
recent evidence (2006–2008) for 532-nm photoselective laser vaporisation and holmium laser
enucleation of the prostate. Eur Urol. 2009;55(6):1345-57. doi: 10.1016/j.eururo.2009.03.070.
Kim JK, Cho MC, Son H, Ku JH, Oh S-J, Paick JS. Patient perception of ejaculatory volume
reduction after holmium laser enucleation of the prostate (HoLEP). Urology. 2017;99:142-7. doi:
1016/j.urology.2016.09.037.
Briganti A, Naspro R, Gallina A, Salonia A, Vavassori I, Hurle R, et al. Impact on sexual function of
holmium laser enucleation versus transurethral resection of the prostate: results of a prospective, 2-
center, randomized trial. J Urol. 2006;175(5):1817-21. doi: 10.1016/S0022-5347(05)00983-3.
Serretta V, Morgia G, Fondacaro L, Curto G, Lo bianco A, Pirritano D, et al. Open prostatectomy
for benign prostatic enlargement in southern Europe in the late 1990s: a contemporary series of 1800
interventions. Urology. 2002;60(4):623-7. doi: 10.1016/s0090-4295(02)01860-5.
Tubaro A, Carter S, Hind A, Vicentini C, Miano L. A prospective study of the safety and efficacy of
suprapubic transvesical prostatectomy in patients with benign prostatic hyperplasia. J Urol.
;166(1):172-6. doi: 10.1016/S0022-5347(05)66102-2.
Kuntz RM, Lehrich K, Ahyai S. Does perioperative outcome of transurethral holmium laser
enucleation of the prostate depend on prostate size? J Endourol. 2004;18(2):183-8. doi:
1089/089277904322959842.
Seki N, Mochida O, Kinukawa N, Sagiyama K, Naito S. Holmium laser enucleation for prostatic
adenoma: analysis of learning curve over the course of 70 consecutive cases. J Urol. 2003;170(5):1847-
doi: 10.1097/01.ju.0000092035.16351.9d.
Cho KJ, Koh JS, Choi JB, Kim JC. Factors associated with early recovery of stress urinary
incontinence following holmium laser enucleation of the prostate in patients with benign prostatic
enlargement. Int Neurourol J. 2018;22(3):200-205. doi: 10.5213/inj.1836092.046.
Endo F, Shiga Y, Minagawa S, Iwabuchi T, Fujisaki A, Yashi M, et al. Anteroposterior dissection
HoLEP: a modification to prevent transient stress urinary incontinence. Urology. 2010;76(6):1451-5. doi:
1016/j.urology.2010.03.071.
Walz J, Burnett AL, Costello AJ, Eastham JA, Graefen M, Guillonneau B, et al. A critical analysis of
the current knowledge of surgical anatomy related to optimization of cancer control and preservation of
continence and erection in candidates for radical prostatectomy. Eur Urol. 2010;57(2):179-92. doi:
1016/j.eururo.2009.11.009.
Jones JS. Saturation biopsy for detecting and characterizing prostate cancer. BJU Int.
;99(6):1340-4. doi: 10.1111/j.1464-410X.2007.06868.x.
Serefoglu EC, Altinova S, Ugras NS, Akincioglu E, Asil E, Balbay MD. How reliable is 12-core
prostate biopsy procedure in the detection of prostate cancer? Can Urol Assoc J. 2013;7(5-6):E293-8.
doi: 10.5489/cuaj.11224.
Abedi AR, Fallah-Karkan M, Allameh F, Ranjbar A, Shadmehr A. Incidental prostate cancer: a 10-
year review of a tertiary center, Tehran, Iran. Res Rep Urol. 2018;10:1-6. doi: 10.2147/RRU.S146159.
Jamali L, Moradi A, Ganji M, Ayati M, Kazeminezhad B, Fazeli Attar Z, et al. Potential Prognostic
Role for SPOP, DAXX, RARRES1, and LAMP2 as an Autophagy Related Genes in Prostate Cancer. Urol J.
doi: 10.22037/uj.v0i0.4935.
Rivera ME, Frank I, Viers BR, Rangel LJ, Krambeck AE. Holmium laser enucleation of the prostate
and perioperative diagnosis of prostate cancer: an outcomes analysis. J Endourol. 2014;28(6):699-703.
doi: 10.1089/end.2014.0009.
Elkoushy MA, Elshal AM, Elhilali MM. Incidental prostate cancer diagnosis during holmium laser
enucleation: assessment of predictors, survival, and disease progression. Urology. 2015;86(3):552-7. doi:
1016/j.urology.2015.06.002.
Ghiasy S, Abedi AR, Moradi A, Hosseini SY, Karkan MF, Sadri G, et al. Is active surveillance an
appropriate approach to manage prostate cancer patients with Gleason Score 3+3 who met the criteria
for active surveillance? Turk J Urol. 2018;45(4):261-4. doi: 10.5152/tud.2018.72920.
Porreca A, Giampaoli M, Bianchi L, D'Agostino D, Romagnoli D, Bianchi FM, et al. Preoperative
multiparametric prostate magnetic resonance imaging: a safe clinical practice to reduce incidental
prostate cancer in Holmium laser enucleation of the prostate. Cent European J Urol.2019;72(2):106-112.
doi: 10.5173/ceju.2019.1943.
Gellhaus PT, Monn MF, Leese J, Flack CK, Lingeman JE, Koch MO, et al. Robot-assisted radical
prostatectomy in patients with a history of holmium laser enucleation of the prostate: feasibility and
evaluation of initial outcomes. J Endourol. 2015;29(7):764-9. doi: 10.1089/end.2014.0767.
Tan A, Liao C, Mo Z, Cao Y. Meta‐analysis of holmium laser enucleation versus transurethral
resection of the prostate for symptomatic prostatic obstruction. Br J Surg. 2007;94(10):1201-8. doi:
1002/bjs.5916.
Yin L, Teng J, Huang CJ, Zhang X, Xu D. Holmium laser enucleation of the prostate versus
transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled
trials. J Endourol. 2013;27(5):604-11. doi: 10.1089/end.2012.0505.
Naqvi SA, Rizvi S, Hasan A. High-energy microwave thermotherapy in patients in urinary
retention. J Endourol. 2000;14(8):677-81. doi: 10.1089/end.2000.14.677.
Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F, et al. Meta-analysis of
functional outcomes and complications following transurethral procedures for lower urinary tract
symptoms resulting from benign prostatic enlargement. Eur Urol. 2010;58(3):384-97. doi:
1016/j.eururo.2010.06.005.
Elmansy H, Baazeem A, Kotb A, Badawy H, Riad E, Emran A, et al. Holmium laser enucleation
versus photoselective vaporization for prostatic adenoma greater than 60 ml: preliminary results of a
prospective, randomized clinical trial. J Urol. 2012;188(1):216-21. doi: 10.1016/j.juro.2012.02.2576.
Elmansy HM, Kotb A, Elhilali MM. Holmium laser enucleation of the prostate: long-term
durability of clinical outcomes and complication rates during 10 years of followup. J Urol.
;186(5):1972-6. doi: 10.1016/j.juro.2011.06.065.
Gupta N, Sivaramakrishna, Kumar R, Dogra PN, Seth A. Comparison of standard transurethral
resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing
benign prostatic hyperplasia of > 40 g. BJU Int. 2006;97(1):85-9. doi: 10.1111/j.1464-410X.2006.05862.x.
Cornu JN, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratzke C, et al. A systematic review
and meta-analysis of functional outcomes and complications following transurethral procedures for
lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol.
;67(6):1066-96. doi: 10.1016/j.eururo.2014.06.017.
Bae J, Oh SJ, Paick JS. The learning curve for holmium laser enucleation of the prostate: a single-
center experience. Korean J Urol. 2010;51(10):688-93. doi: 10.4111/kju.2010.51.10.688.
Kampantais MS, Dimopoulos MP, Tasleem MA, Acher MP, Gordon MK, Young A. Assessing the
learning curve of Holmium Laser Enucleation of Prostate (HoLEP). A systematic review. Urology. 2018.
doi: 10.1016/j.urology.2018.06.012.
Lourenco T, Armstrong N, N'Dow J, Nabi G, Deverill M, Pickard R, et al. Systematic review and
economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic
enlargement. Health Technol Assess. 2008;12(35):iii, ix-x, 1-146, 169-515. doi: 10.3310/hta12350.
Mavuduru RM, Mandal AK, Singh SK, Acharya N, Agarwal M, Garg S, et al. Comparison of HoLEP
and TURP in terms of efficacy in the early postoperative period and perioperative morbidity. Urol Int.
;82(2):130-5. doi: 10.1159/000200786.
Kuntz RM, Lehrich K, Ahyai S. Transurethral holmium laser enucleation of the prostate compared
with transvesical open prostatectomy: 18-month follow-up of a randomized trial. J Endourol.
;18(2):189-91. doi: 10.1089/089277904322959851.
- Abstract Viewed: 1186 times
- PDF Downloaded: 709 times